1. Home
  2. TCBI vs ICUI Comparison

TCBI vs ICUI Comparison

Compare TCBI & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Texas Capital Bancshares Inc.

TCBI

Texas Capital Bancshares Inc.

HOLD

Current Price

$99.27

Market Cap

4.2B

Sector

Finance

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$141.13

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCBI
ICUI
Founded
1996
1984
Country
United States
United States
Employees
1785
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.5B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
TCBI
ICUI
Price
$99.27
$141.13
Analyst Decision
Hold
Strong Buy
Analyst Count
13
3
Target Price
$100.92
$169.00
AVG Volume (30 Days)
458.8K
251.3K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
100.62
EPS
N/A
1.20
Revenue
N/A
$2,231,262,000.00
Revenue This Year
$14.76
N/A
Revenue Next Year
$7.47
$4.46
P/E Ratio
$15.46
$114.95
Revenue Growth
N/A
N/A
52 Week Low
$75.41
$107.02
52 Week High
$108.92
$160.29

Technical Indicators

Market Signals
Indicator
TCBI
ICUI
Relative Strength Index (RSI) 47.89 59.27
Support Level $96.55 $139.88
Resistance Level $102.72 $142.31
Average True Range (ATR) 2.16 4.20
MACD -0.09 0.09
Stochastic Oscillator 41.01 72.91

Price Performance

Historical Comparison
TCBI
ICUI

About TCBI Texas Capital Bancshares Inc.

Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: